HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATIN
Open Access
- 1 June 2003
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 31 (6), 705-13
- https://doi.org/10.1124/dmd.31.6.705
Abstract
Previous studies have shown that cisplatin requires metabolic activation to become nephrotoxic. The activation is proposed to be via the metabolism of a glutathione-platinum conjugate to a cysteinyl-glycine-platinum conjugate, which is further processed to a cysteine conjugate. Preincubating cisplatin with glutathione (GSH), cysteinyl-glycine, or N-acetylcysteine (NAC) results in a transient increase in the toxicity of cisplatin toward renal proximal tubular cells. In this study, the preincubation solutions were analyzed by high pressure liquid chromatography (HPLC), atomic absorption spectrometry, and mass spectrometry (MS) to characterize the formation and structure of the platinum conjugates. HPLC analysis of the cisplatin-GSH, cisplatin-cysteinyl-glycine, and cisplatin-NAC preincubation solutions revealed two new platinum-containing peaks in each of the solutions. MS-MS analysis of the peaks revealed a diplatinum- and a monoplatinum conjugate in each of the solutions. Analysis of the composition and toxicity of the solutions with time showed that the transient increase in toxicity correlated with the formation of the monoplatinum conjugate whereas prolonged preincubation decreased toxicity and correlated with the formation of the diplatinum conjugate. The monoplatinum-monoglutathione conjugate is a substrate for γ-glutamyl transpeptidase, an enzyme that is essential for the nephrotoxicity of cisplatin. The monoplatinum-mono-NAC conjugate can be deacetylated to a cysteine conjugate, which is a substrate for pyroxidol phosphate (PLP)-dependent cysteine S-conjugate β-lyase. This PLP-dependent enzyme is proposed to catalyze the final step in the metabolic activation of cisplatin. Identification of the structure and toxicity of these conjugates further elucidates the metabolism of cisplatin to a nephrotoxin.Keywords
This publication has 20 references indexed in Scilit:
- Toxic, halogenated cysteine S-conjugates and targeting of mitochondrial enzymes of energy metabolismBiochemical Pharmacology, 2002
- γ-Glutamyl Transpeptidase-Deficient Mice Are Resistant to the Nephrotoxic Effects of CisplatinThe American Journal of Pathology, 2001
- GLUTATHIONE-DEPENDENT BIOACTIVATION OF HALOALKENESAnnual Review of Pharmacology and Toxicology, 1998
- Kinetic analysis of the cis-diamminedichloroplatinum(II)-cysteine reaction: Implications to the extent of platinum-DNA bindingJournal of Inorganic Biochemistry, 1997
- Cisplatin nephrotoxicity: Inhibition of γ-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidneyAmerican Journal of Obstetrics and Gynecology, 1996
- Characterization of cisplatin-glutathione adducts by liquid chromatography-mass spectrometry evidence for their formation in vitro but not in vivo after concomitant administration of cisplatin and glutathione to rats and cancer patientsJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- The formation of both a mono- and a bis-substituted glutathione conjugate of hexachlorobutadiene by isolated hepatocytes and following in vivo administration to the ratChemico-Biological Interactions, 1985
- Gamma-glutamyl transpeptidase – its role in hepatocarcinogenesisCarcinogenesis: Integrative Cancer Research, 1985
- Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatinBiochemical Pharmacology, 1984
- In vivoandin vitronephrotoxicity of the cysteine conjugate of hexachlorobutadieneJournal of Toxicology and Environmental Health, 1983